The AMWA Conference 2024: A Celebration of Expertise, Innovation, and Community

Dr. Sonica S Batra, Indegene’s head of Regulatory business Operations, led a lively roundtable discussion on “Protocol Development: Challenges, Best Practices, and Recent Trends.” This session wasn’t just a discussion— it was a deep dive into the critical role of clinical trial protocols in ensuring the success of clinical research. The session highlighted how the right protocols lay the foundation for effective trial design, patient safety, and data integrity.

In one of the most anticipated sessions, Cody Nichols demystified a crucial yet complex topic: "Estimands in Clinical Trials: A Practical Framework for Protocol Writing and Analysis."

In his session, Vladimir Penkrat, Indegene’s head of the Regulatory Affairs practice delved into the best practices toward assessing and preparing for technology selection and implementation specifically as it relates to Generative AI. He discussed expectation of Generative AI, offering practical insights into how these tools can be leveraged to enhance the writing process.

While AI uses rule-based systems to process data and make decisions, GenAI goes beyond that, capable of generating new content autonomously. This shift opens up new possibilities for medical writing, enabling automation of tasks traditionally managed manually and streamlining workflows.

Tasks like data analysis, drafting reports, and even reviewing documents for regulatory compliance can be significantly sped up with AI-powered tools. By automating these time-consuming processes, medical writers can focus more on strategic work, like creating high-quality content and enhancing the impact of their submissions.

AI doesn’t just make work faster—it enhances accuracy, reduces human error, and ensures that content is consistent and compliant. With AI’s help, medical writers can achieve better results with less effort, making their work not only quicker but also more impactful.

How can we ensure that AI tools deliver the quality and accuracy required in highly regulated environments? Emphasis on continuous quality control, audits, and governance is necessary to ensure that AI tools perform as expected, especially when their outputs influence patient safety and regulatory approval.

Rather than replacing medical writers, AI should be seen as a powerful tool that writers can use to enhance their work. Medical writers need to be involved in the development and implementation of AI systems, ensuring that the technology aligns with industry standards and delivers high-quality, compliant content. By taking an active role in overseeing AI performance, medical writers can ensure that technology works in their favor, rather than undermining it.

AMWA 2024 underscored one powerful truth: medical writers are the architects of clarity in an increasingly complex world. The event served as a rallying cry to innovate, collaborate, and push the boundaries of what’s possible in medical writing. Yet, this is just the beginning of the journey.